Prospective Follow-up of Relapse Myeloma Patients After Previous Exposure to Bortezomib and Lenalidomide Treated on Pomalidomide and Dexamethasone
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2019
Price : $35 *
At a glance
- Drugs Pomalidomide (Primary) ; Cyclophosphamide; Cyclophosphamide; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- Sponsors National University Hospital (Singapore)
- 25 Feb 2019 Status changed from active, no longer recruiting to completed.
- 17 Jun 2018 Results (n=130; 17 Jan 2018) presented at the 23rd Congress of the European Haematology Association.
- 13 May 2018 Planned number of patients changed from 40 to 100.